Non-Hodgkin's Lymphoma in Northern Sweden: A retrospective analysis of morphologic diagnosis and stage in a material from the Swedish Cancer Registry

References

• Rappaport H. Tumors of the hematopoietic system. Atlas of tumor pathology. Sect. 3, Fasc. 8. Armed Forces Institute of Pathology, Washington, DC 1966; 97–161
   Google Scholar
• Gerard-Marchant R, Hamlin I, Lennert K, Rilke F, Stansfeld G, van Unnik J AM. Classification of non-Hodgkin's lymphomas. Lancet 1974; 2: 406–8
   Web of Science ®Google Scholar
• Lennert K. Malignant lymphomas other than Hodgkin's disease. Springer Verlag, Berlin, Heidelberg, New York 1978
   Google Scholar
• Stansfeld A G, Diebold J, Kapanci Y, et al. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292–3
   PubMed Web of Science ®Google Scholar
• Lukes R J, Collins R D. Immunologic characterization of human malignant lymphomas. Cancer 1974; 34: 1488–503
   PubMed Web of Science ®Google Scholar
• National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Cancer 1982; 49: 2112–35
   PubMed Web of Science ®Google Scholar
• Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register—Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 1984; 23: 305–13
   PubMed Web of Science ®Google Scholar
• Martinsson U, Glimelius B, Sundström C. Lymphoma incidence in a Swedish county during 1969–1987. Acta Oncol 1992; 31: 275–82
   PubMed Web of Science ®Google Scholar
• World Health Organization. International classification of diseases. Manual of the international statistical classification of disease, injuries and causes of death. Based on recommendations of the ninth revision conference 1975 and adopted by the 29th World Health Assembly. World Health Organization, Geneva 1977
   Google Scholar
• National Board of Health and Welfare. The Cancer Registry. Cancer incidence in Sweden 1978, 1979, 1980, 1981 and 1982 respectively. Ann Publ., Stockholm 1985, 1982, 1982, 1983, 1984 and
   Google Scholar
• Dige U, Johansson H, Lenner P, Norberg B, Roos G. Hodgkin's disease in Northern Sweden 1971–1981. I. A histo-pathological reevaluation of 223 cases. Acta Oncol 1991; 30: 593–6
   PubMed Web of Science ®Google Scholar
• Cheson B D, Bennett J M, Kanti R R, et al. Guidelines for clinical protocols for chronic lymphocytic lukemia: Recommendations of the National Cancer Institute-sponsored Working Group. Am J Hematol 1988; 29: 152–63
   PubMed Web of Science ®Google Scholar
• Carbone P P, Kaplan H S, Musshoff K, Smithers D W, Tubi-Ana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res 1971; 31: 1860–1
   PubMed Web of Science ®Google Scholar
• Brittinger G, Bartels H, Common H, et al. Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas. Results of a prospective multicenter study by the Kiel lymphoma study group. Hematol Oncol 1984; 2: 269–306
   PubMedGoogle Scholar
• Lenner P, Lundgren E, Damber L. Clinico-pathologic correlation in non-Hodgkin's lymphoma. I. Retrospective analysis using the Lukes and Collins classification. Acta Radiol Oncol 1979; 18: 177–91
   Google Scholar
• Glimelius B, Sundström C. Morphologic classification of non-Hodgkin's lymphoma—I. Retrospective analysis using the Kiel classification. Acta Radiol Oncol 1982; 21: 289–97
   PubMed Web of Science ®Google Scholar
• Cavallin-Ståhl E, Landberg T, Lindberg L G, Åkerman M. A retrospective clinico-pathologic study of non-Hodgkin's lymphomas classified according to the nomenclatures of Lennert and Rappaport. Acta Med Scand 1981; 209: 407–14
   PubMedGoogle Scholar
• Nabholtz J M, Friedman S, Bastien H, Cuisenier J, Horiot J C, Guerrin B. A clinico-pathological and prognostic analysis of non-Hodgkin lymphoma. A study of 203 patients. Acta Oncol 1988; 27: 489–95
   PubMed Web of Science ®Google Scholar
• Meuge C, Hoerni B, de Mascarel A, et al. Non-Hodgkin malignant lymphomas. Clinico-pathologic correlations with the Kiel classification. A retrospective analysis of a series of 274 cases. Eur J Cancer 1978; 14: 587–92
   Web of Science ®Google Scholar
• Höffken K, Schweers K, Kath R, Pfeiffer R, Seeber S, Schmidt C G. Zur Prognose von Non-Hodgkin-Lymphomen. Retrospective analysis on 634 patients of the West German Tumor Center using the Kiel classification and the NCI new working formulation for clinical usage. Tumor Diagn Ther 1985; 6: 14–9
   Google Scholar
• Monfardini S, Rilke F, Valagussa P, et al. A clinico-pathologic study in advanced non-Hodgkin's lymphomas treated with sequential non-cross-resistant regimens. Comparison of the Working Formulation with the Rappaport and Kiel classifications. Eur J Cancer Clin Oncol 1984; 20: 609–17
   PubMedGoogle Scholar
• Nathwani B N, Hun Kim Rappaport H, Solomon J, Fox M. Non-Hodgkin's lymphomas. A clinico-pathological study comparing two classifications. Cancer 1978; 41: 303–25
   PubMed Web of Science ®Google Scholar
• Anderson T, Chabner B A, Young R C, et al. Malignant lymphoma. I. Histology and staging of 473 patients at the National Cancer Institute. Cancer 1982; 50: 2699–707
   PubMed Web of Science ®Google Scholar
• Straus D J, Filippa D A, Lieberman H, et al. The non-Hodgkin's lymphomas. I. A retrospective clinical and pathological analysis of 499 cases diagnosed between 1958 and 1969. Cancer 1983; 51: 101–9
   PubMed Web of Science ®Google Scholar
• Yancik R. Frame of reference: Old age as the context for the prevention and treatment of cancer. Perspectives on prevention and treatment of cancer in the elderly, R Yancik. Raven, New York 1983; 5–17
   Google Scholar
• Binet J L, Leporrier M, Dighiero G, et al. A clinical staging system for chronic lymphocytic leukemia: Prognostic significance. Cancer 1977; 40: 855–64
   PubMed Web of Science ®Google Scholar
• Shaerer R, Lutz J M, Ménégoz F, Ferley J P, Swierz P, Mousseau M. Lymphoma registration: Difficulties and results of a population-based registry. Non-Hodgkin's lymphomas: New techniques and treatments, Vrousos Sotto, Vincent Sotto. Karger, Basel 1985; 6–12, 4th Cancer Res Workshop Grenoble 1984
   Google Scholar
• Lieberman P H, Filippa D A, Straus D J, Tzvi Thaler H, Cirrin-Cione C, Clarkson B. Evaluation of malignant lymphomas using three classifications and the working Formulation. Am J Med 1986; 81: 365–80
   PubMed Web of Science ®Google Scholar
• Ersboll J, Schoultz H B, Hougaard P, Nissen Nis I, Hou-Jensen K. Comparison of the Working Formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel and Lukes & Collins classifications. Cancer 1985; 55: 2442–58
   PubMed Web of Science ®Google Scholar
• Fraser R W, Chism S E, Stern R, Fu K K, Buschke F. Clinical course of early extranodal non-Hodgkin's lymphomas. Int J Radiat Oncol Biol Phys 1979; 5: 177–83
   PubMed Web of Science ®Google Scholar
• Rudders R A, Ross M E, DeLellis R A. Primary extranodal lymphoma. Response to treatment and factors influencing prognosis. Cancer 1978; 42: 406–16
   PubMed Web of Science ®Google Scholar